Related Experiment Videos

Tumor suppressor p16INK4A: determination of solution structure and analyses of its interaction with cyclin-dependent

I J Byeon1, J Li, K Ericson

  • 1Department of Chemistry, Ohio State University, Columbus 43210, USA.

Molecular Cell
|July 14, 1998
PubMed

Insights

The tumor suppressor p16INK4A structure was determined by NMR, revealing key binding sites for cdk4. This research identified critical regions for p16INK4A-cdk4 interaction, aiding in understanding cancer development.

Area of Science:

  • Molecular Biology
  • Structural Biology
  • Biochemistry

Background:

  • The p16INK4A protein is a critical tumor suppressor involved in cell cycle regulation.
  • Understanding the structural basis of p16INK4A interactions with its targets, like cdk4, is crucial for cancer research.

Purpose of the Study:

  • To determine the solution structure of the tumor suppressor p16INK4A.
  • To identify the key regions involved in the recognition and binding between p16INK4A and cdk4.
  • To analyze the structural and functional impact of tumorigenic mutations in p16INK4A.

Main Methods:

  • Nuclear Magnetic Resonance (NMR) spectroscopy was used to determine the solution structure of p16INK4A.
  • Construction and analysis of twelve tumorigenic p16INK4A mutants.
  • Rational design of novel mutants.
  • Site-directed mutagenesis and functional analysis of cdk4.
  • Molecular docking experiments.

Main Results:

  • The tertiary structure of p16INK4A was elucidated, revealing four helix-turn-helix motifs linked by three loops.
  • Key recognition regions on both p16INK4A and cdk4 involved in their interaction were identified.
  • A specific 58-residue N-terminal fragment of cdk4 was found to be essential for p16INK4A binding.
  • Mutational analysis confirmed the importance of this cdk4 region.
  • Docking experiments provided insights into potential binding modes between p16INK4A and cdk4.

Conclusions:

  • The structural and functional characterization of p16INK4A and its interaction with cdk4 provides a foundation for understanding its role in tumor suppression.
  • Identification of critical binding interfaces advances the design of targeted cancer therapies.
  • Further investigation into p16INK4A mutants and their binding dynamics can reveal new therapeutic strategies.

Related Concept Videos